Sellbyville, Delaware, Jan. 22, 2019 (GLOBE NEWSWIRE) --
Germany dominated the Europe POC testing market and was valued around USD 1,717.4 million in the year 2017. In the Federal Republic of Germany, point-of-care systems are increasingly used within hospitals and medical practices. Other medical facilities where point of care testing is widely used includes outpatient nursing care, pharmacies and home visits. Therefore, growing adoption of point of care testing across the nation will drive the regional market growth.
Global Point of Care Testing Market is projected to surpass USD 34.2 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increase in number of pathology labs and services equipped with advanced diagnostic equipment in North America will be one of the major factors driving the growth of POC testing market. Healthcare infrastructure development has resulted in the industry growth. Majority of the population staying in developed countries rely on healthcare facilities developed by the public healthcare sector, that will positively impact the industry growth.
Molecular diagnostics holds significant role in the field of microbiology. Conventional culture method is not helpful in obtaining timely results. Molecular testing technology allows nucleic acid detection directly through amplification and screening of sample. Real time PCR is used for this purpose. Industry players have been focusing their efforts on developing new point of care molecular diagnostic technologies to deliver faster results with high accuracy and specificity. Hence, increase in research and development will augment the market growth in the forthcoming years.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3086
High cost of the tests and the devices will be one of the major market hampering factors. The biomolecules used in developing point of care tests are complex in nature and expensive. Hence, the aforementioned factors will hinder the market growth.
Pregnancy and fertility testing products market held a significant amount of market share in the year 2017 and was valued around USD 2,384.7 million. Factors such as heredity, late child bearing and changing lifestyles are the major risk factors that lead to infertility. Hence, increase in number of infertility cases will significantly contribute to assisted reproductive technology market growth in forthcoming years.
Browse key industry insights spread across 385 pages with 540 market data tables & 17 figures & charts from the report, “Point of Care Testing Market” i n detail along with the table of contents:
https://www.gminsights.com/industry-analysis/...ing-market
Solid phase technology market is estimated to witness a growth of 9.2% during the forecast time period. Presence of HIV antibodies will result in a spot or dot with the help of a signal reagent. Such tests have high sensitivity and are designed to aid in the diagnosis of diseases along with the determination of antibody levels, thereby driving the segmental growth.
Prescription-based testing market was valued around USD 8,640.0 million in the year 2017. Diagnostic uncertainty escalates the risk of unnecessary antibiotic prescribing hence point of care testing is considered as key to rational prescribing. Issuance of such guidelines favoring use of point of care testing will drive segmental growth over the forecast timeframe.
The use of point of care testing devices in nephrology testing is projected to grow at a CAGR of 7.4% during the estimation period. Increasing incidence of kidney failure and kidney diseases will stimulate demand for nephrology testing over the forecast period. Rising number of people suffering from diabetes, high blood pressure, obesity, and other risk factors such as smoking leading to kidney diseases will fuel demand for nephrology testing over the forecast timeframe.
Japan Point of care testing market is projected to grow at a CAGR of 8.7% over the projection period. As per the statistics published by the World Health Organization (WHO), more than 20,000 people were suffering from HIV and tuberculosis in Japan in the year 2016. This rising incidence stimulates the demand for point of care diagnostics tests resulting in growing demand and adoption rate of point of care testing devices in the country.
Major companies operating in the point of care testing market include Abbott, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Siemens AG, and Abaxis, among others. The company’s major strategy includes launching of technologically advanced new and innovative products. Industry participants are also focusing on product portfolio expansion to suit the requirements of different healthcare settings in terms of test volumes, assay menu and budget to stay ahead of the competition.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3086
Browse Related Reports:
- Point of Care Molecular Diagnostics Market Size Forecast 2017 – 2024
Global Point of Care Molecular Diagnostics Market exceeded USD 1 billion in 2016, with growth forecast over 9% CAGR from 2017 to 2024 driven by increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence.
https://www.gminsights.com/industry-analysis/...ics-market
- Biosensors Market Size Outlook 2018 – 2024
The Biosensors Market exceeded USD 17 billion in 2017 and is expected to witness growth of around 8% CAGR from 2018 to 2024 as increasing prevalence of diabetes will propel the industry growth. https://www.gminsights.com/industry-analysis/...ors-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Web: https://www.gminsights.com Blog: http://news-researchers.com/
